follow our data >[/ce_button]
IsoPlexis' systems are revealing choice in novel bispecific development targeting the tumor microenvironment
Our products help identify methodologies for increasing potency in cell therapy bioprocessing
Our systems are identifying pre-infusion cell therapy product metrics (PSITM) that correlate with in vivo outcome
Connect: IsoPlexis’ systems uniquely connect each immune cell to its cytokine profile, which orchestrates response
Correlate: The data and experimental results from critical immune cell subsets correlate to in vivo physiology and outcome
Empower: This data empowers better informed, faster decisions and interactions from discovery to predicting response
Join us at one of our many worldwide events and learn more about how our single-cell systems are creating what is next in biological discovery and therapeutics
See customer data at conferences to see what’s next
Join in our webinars to find out how our systems work
Attend our user group meetings to see impactful data
IsoPlexis places IsoLight instrument at Fred Hutchinson Cancer Research Center.
IsoPlexis and Kite Pharma research offers hope for targeted CAR-T treatment.
IsoPlexis' new IsoLight instrument receives the Red Dot award for highest design quality.